Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-7.2%
5Y CAGR-8.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-7.2%/yr
vs +8.0%/yr prior
5Y CAGR
-8.0%/yr
Consistent
Acceleration
-15.2pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $42.91M | -39.9% |
| 2024 | $71.33M | -19.3% |
| 2023 | $88.40M | +64.8% |
| 2022 | $53.64M | -45.3% |
| 2021 | $97.99M | +50.6% |
| 2020 | $65.08M | +2.8% |
| 2019 | $63.34M | +60.8% |
| 2018 | $39.39M | +1052.5% |
| 2017 | $3.42M | - |